{"id":"NCT01310777","sponsor":"Alcon Research","briefTitle":"Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension","officialTitle":"Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL/Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL Eye Drops, Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2011-03-09","resultsPosted":"2014-03-06","lastUpdate":"2014-03-06"},"enrollment":771,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Open-Angle Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension","otherNames":[]},{"type":"DRUG","name":"Brinzolamide 1% ophthalmic suspension","otherNames":["AZOPTâ„¢"]},{"type":"DRUG","name":"Brimonidine tartrate 0.2% ophthalmic solution","otherNames":[]}],"arms":[{"label":"Brinz/Brim","type":"EXPERIMENTAL"},{"label":"Brinz","type":"ACTIVE_COMPARATOR"},{"label":"Brim","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the safety and efficacy of Brinzolamide/Brimonidine in lowering intraocular pressure (IOP) relative to each of its individual active components in patients with open-angle glaucoma or ocular hypertension.","primaryOutcome":{"measure":"Mean Diurnal IOP Change From Baseline at Month 3","timeFrame":"Baseline (Day 1), Month 3","effectByArm":[{"arm":"Brinz/Brim","deltaMin":-7.9,"sd":0.22},{"arm":"Brinz","deltaMin":-6.5,"sd":0.23},{"arm":"Brim","deltaMin":-6.4,"sd":0.24}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":193},"commonTop":["Ocular hyperaemia","Dry Mouth","Dysgeusia","Conjunctivitis","Vision Blurred"]}}